Evaluation of FoxP3 expression in peripheral T-cell lymphoma

被引:21
|
作者
Bonzheim, Irina [1 ]
Geissinger, Eva [1 ]
Tinguely, Marianne [3 ]
Roth, Sabine [1 ]
Grieb, Tina [1 ]
Reimer, Peter [2 ]
Wilhelm, Martin [4 ]
Rosenwald, Andreas [1 ]
Mueller-Hermelink, Hans Konrad [1 ]
Ruediger, Thomas [5 ]
机构
[1] Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Med Klin & Poliklin 2, D-97080 Wurzburg, Germany
[3] Inst Clin Pathol, Zurich, Switzerland
[4] Klinikum Nuremberg, Med Klin 5, Nurnberg, Germany
[5] Stadt Klinikum Karlsruhe, Inst Pathol, Karlsruhe, Germany
关键词
peripheral T-cell lymphoma not otherwise specified; PTCL-NOS; regulatory T cells; FoxP3; anaplastic large cell lymphoma; ALCL;
D O I
10.1309/L65GWEQ803PP6VX1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Peripheral T-cell lymphomas (PTCLs) are biologically heterogeneous and have not been successfully correlated with specific T-cell subsets. We investigated PTCL, not otherwise specified (NOS), angioimmunoblastic T-cell lymphoma (AILT), and anaplastic large cell lymphoma (ALCL) cases for FoxP3 expression to determine a potential derivation from regulatory T (T(reg)) cells. One PTCL-NOS case strong v expressed FoxP3 in the neoplastic T cells and showed unusual histomorphologic features with a dense infiltration of the lymph node by immunoblastic T cells and almost no reactive background infiltrate. The patient died shortly after diagnosis, suggesting that biologic properties of T(reg) cells may have contributed to the rapidly fatal clinical course. All remaining PTCL-NOS and AILT cases showed FoxP3 positivity only in the reactive infiltrate. Among ALCL cases, 4 of 6 ALK+ cases displayed weak and inhomogeneous FoxP3 expression in the tumor cells. FoxP3+ PTCL-NOS presumably derived from bona fide T(reg) cells occurs but seems rare in the Western population.
引用
收藏
页码:613 / 619
页数:7
相关论文
共 50 条
  • [41] Inhibition of clonal expansion by Foxp3 expression as a mechanism of controlled T-cell responses and autoimmune disease
    Guo, Linjie
    Tian, Jun
    Marinova, Ekaterina
    Zheng, Biao
    Han, Shuhua
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (01) : 71 - 80
  • [42] Foxp3 expression in T regulatory cells and other cell lineages
    Devaud, Christel
    Darcy, Phillip K.
    Kershaw, Michael H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (09) : 869 - 876
  • [43] Human T-cell leukemia virus type 1 and Foxp3 expression: viral strategy in vivo
    Miyazato, Paola
    Matsuoka, Masao
    INTERNATIONAL IMMUNOLOGY, 2014, 26 (08) : 419 - 425
  • [44] An evaluation of mogamulizumab for the treatment of peripheral T-cell lymphoma
    Munakata, Wataru
    Tobinai, Kensei
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (07): : 735 - 742
  • [45] FOXP3 positive regulatory T-cells in cutaneous T-cell lymphomas
    Gjerdrum, Lise Mette
    Woetmann, Andreas
    Odum, Niels
    Ralfkiaer, Elisabeth
    VIRCHOWS ARCHIV, 2008, 452 : S4 - S4
  • [46] Primary cutaneous T-cell lymphoma expressing FOXP3: A case report supporting the existence of malignancies of regulatory T cells
    Marzano, Angelo V.
    Vezzoli, Pamela
    Fanoni, Daniele
    Venegoni, Luigia
    Berti, Emilio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (02) : 348 - 355
  • [47] PERIPHERAL T-CELL LYMPHOMA
    BOEHRINGER, B
    OSTRONOFF, M
    MACEDO, MCA
    CONCHON, M
    MEDEIROS, RS
    MASSUMOTO, CM
    DULLEY, F
    MENEZES, Y
    VASALO, J
    LLACCER, PD
    POZZI, D
    CHAMONE, DF
    BLOOD, 1994, 84 (10) : A639 - A639
  • [48] Peripheral T-cell lymphoma
    Cookson, Emma
    LANCET HAEMATOLOGY, 2021, 8 (01): : E17 - E17
  • [49] PERIPHERAL T-CELL LYMPHOMA
    LIANG, R
    TODD, D
    CHAN, TK
    WONG, KL
    HO, F
    LOKE, SL
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (05) : 750 - 755
  • [50] Peripheral T-cell lymphoma
    Foss, Francine M.
    Zinzani, Pier Luigi
    Vose, Julie M.
    Gascoyne, Randy D.
    Rosen, Steven T.
    Tobinai, Kensei
    BLOOD, 2011, 117 (25) : 6756 - 6767